Intevac Announces Second Quarter 2016 Financial Results
Mon, August 1 2016
“The second quarter of 2016 marked an inflection point in the execution
of our strategic growth initiatives for our Thin-film Equipment
business,” commented
“Photonics revenues increased 9% from the first quarter, primarily due to an increase in contract R&D sales, supporting our confidence that we will see a similar level of Photonics business this year, compared to 2015,” added Mr. Blonigan. “The same can be said for our hard-drive equipment revenues this year, which we also expect to be similar to last year. The revenue growth forecast for 2016 will therefore come from our new Thin-film Equipment systems, which require customer sign-off for revenue recognition. Timing of customer sign-off can be difficult to predict, but, with most of the systems scheduled to ship before year end, a majority of the current Thin-film Equipment backlog will be received in cash before year end.”
($ Millions, except per share amounts) | Q2 2016 | Q2 2015 | ||||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | |||||||||||||
Net Revenues | $ | 14.9 | $ | 14.9 | $ | 20.5 | $ | 20.5 | ||||||||
Operating Income (Loss) | $ | (3.8 | ) | $ | (4.0 | ) | $ | 0.3 | $ | 0.1 | ||||||
Net Income (Loss) | $ | (3.5 | ) | $ | (3.6 | ) | $ | 0.0 | $ | (0.2 | ) | |||||
Net Income (Loss) per Share |
$ | (0.17 | ) | $ | (0.18 | ) | $ | 0.00 | $ | (0.01 | ) | |||||
Six Months Ended | Six Months Ended | |||||||||||||||
|
|
|||||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | |||||||||||||
Net Revenues | $ | 28.6 | $ | 28.6 | $ | 40.3 | $ | 40.3 | ||||||||
Operating Loss | $ | (10.1 | ) | $ | (10.3 | ) | $ | (2.7 | ) | $ | (2.7 | ) | ||||
Net Loss | $ | (9.8 | ) | $ | (9.9 | ) | $ | (2.9 | ) | $ | (2.9 | ) | ||||
Net Loss per Share | $ | (0.48 | ) | $ | (0.48 | ) | $ | (0.13 | ) | $ | (0.13 | ) | ||||
Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) changes in fair value of contingent consideration liabilities associated with business combinations; and (2) restructuring charges. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section.
Second Quarter 2016 Summary
The net loss for the quarter was
Revenues were
Thin-film Equipment gross margin was 36.2% compared to 41.0% in the second quarter of 2015 and 9.0% in the first quarter of 2016. The decline from the second quarter of 2015 was primarily due to lower revenues and lower factory absorption. The improvement from the first quarter of 2016 was primarily due to a higher mix of higher-margin upgrades and improved factory absorption.
Photonics gross margin was 44.4% compared to 34.5% in the second quarter of 2015 and 41.5% in the first quarter of 2016. The improvement from the second quarter of 2015 was due primarily to improved sensor yields and lower inventory provisions. The improvement from the first quarter of 2016 was due primarily to favorable sensor yields and higher research and development revenues. Consolidated gross margin was 41.1%, compared to 38.2% in the second quarter of 2015 and 28.2% in the first quarter of 2016.
R&
Order backlog totaled
The Company ended the quarter with
First Six Months 2016 Summary
The net loss was
Revenues were
Thin-film Equipment gross margin was 23.2%, compared to 35.0% in the first six months of 2015, primarily due to lower revenues, higher factory overhead expenses and higher inventory charges. We recognized revenue on one VERTEX system in both the first half of 2016 and the first half of 2015 and on one 200 Lean system in the first half of 2015. Photonics gross margin was 43.0% compared to 38.3% in the first six months of 2015, reflecting improved sensor yields and lower inventory provisions. Consolidated gross margin was 34.9%, compared to 36.5% in the first six months of 2015.
R&
Use of Non-GAAP Financial Measures
Management uses non-GAAP results to evaluate the company’s operating and
financial performance in light of business objectives and for planning
purposes. These measures are not in accordance with GAAP and may differ
from non-GAAP methods of accounting and reporting used by other
companies.
Conference Call Information
The company will discuss its financial results and outlook in a
conference call today at 1:30 p.m. PDT (4:30 p.m. EDT). To participate
in the teleconference, please call toll-free (877) 334-0811 prior to the
start time. For international callers, the dial-in number is
(408) 427-3734. You may also listen live via the
About
In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.
In our Photonics business, we are a recognized leading developer of
advanced high-sensitivity digital sensors, cameras and systems that
primarily serve the defense industry. We are the provider of integrated
digital imaging systems for most
For more information call 408-986-9888, or visit the Company's website at www.intevac.com.
200 Lean® is a registered trademark and
Safe Harbor Statement
This press release includes statements that constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995 (the “Reform Act”).
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, in thousands, except per share amounts) |
||||||||||||||||||
Three months ended | Six months ended | |||||||||||||||||
|
|
|
|
|||||||||||||||
Net revenues | ||||||||||||||||||
Thin-film Equipment | $ | 6,088 | $ | 11,494 | $ | 11,668 | $ | 22,122 | ||||||||||
Photonics | 8,830 | 8,964 | 16,914 | 18,221 | ||||||||||||||
Total net revenues | 14,918 | 20,458 | 28,582 | 40,343 | ||||||||||||||
Gross profit | 6,127 | 7,806 | 9,982 | 14,727 | ||||||||||||||
Gross margin | ||||||||||||||||||
Thin-film Equipment | 36.2 | % | 41.0 | % | 23.2 | % | 35.0 | % | ||||||||||
Photonics | 44.4 | % | 34.5 | % | 43.0 | % | 38.3 | % | ||||||||||
Consolidated | 41.1 | % | 38.2 | % | 34.9 | % | 36.5 | % | ||||||||||
Operating expenses | ||||||||||||||||||
Research and development | 4,977 | 2,947 | 10,154 | 7,555 | ||||||||||||||
Selling, general and administrative | 5,115 | 4,750 | 10,094 | 10,029 | ||||||||||||||
Acquisition-related1 | (158 | ) | (174 | ) | (142 | ) | (200 | ) | ||||||||||
Total operating expenses | 9,934 | 7,523 | 20,106 | 17,384 | ||||||||||||||
Total operating income (loss) | (3,807 | ) | 283 | (10,124 | ) | (2,657 | ) | |||||||||||
Income (loss) from operations | ||||||||||||||||||
Thin-film Equipment | (3,674 | ) | 6 | (9,119 | ) | (3,291 | ) | |||||||||||
Photonics | 1,512 | 1,275 | 1,919 | 2,752 | ||||||||||||||
Corporate | (1,645 | ) | (998 | ) | (2,924 | ) | (2,118 | ) | ||||||||||
Total operating income (loss) | (3,807 | ) | 283 | (10,124 | ) | (2,657 | ) | |||||||||||
Interest and other income (expense) | 87 | (13 | ) | 125 | 66 | |||||||||||||
Income (loss) before income taxes | (3,720 | ) | 270 | (9,999 | ) | (2,591 | ) | |||||||||||
Provision for (benefit from) income taxes | (230 | ) | 258 | (204 | ) | 290 | ||||||||||||
Net income (loss) | $ | (3,490 | ) | $ | 12 | $ | (9,795 | ) | $ | (2,881 | ) | |||||||
Net income (loss) per share | ||||||||||||||||||
Basic and Diluted | $ | (0.17 | ) | $ | 0.00 | $ | (0.48 | ) | $ | (0.13 | ) | |||||||
Weighted average common shares outstanding | ||||||||||||||||||
Basic | 20,691 | 22,630 | 20,621 | 22,929 | ||||||||||||||
Diluted | 20,691 | 22,912 | 20,621 | 22,929 |
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except par value) |
||||||||||
|
|
|||||||||
(Unaudited) | (see Note) | |||||||||
ASSETS | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short-term investments | $ | 35,388 | $ | 36,954 | ||||||
Accounts receivable, net | 16,808 | 12,310 | ||||||||
Inventories | 22,487 | 18,760 | ||||||||
Prepaid expenses and other current assets | 1,621 | 1,712 | ||||||||
Total current assets | 76,304 | 69,736 | ||||||||
Long-term investments | 5,226 | 9,673 | ||||||||
Restricted cash | 1,780 | 1,780 | ||||||||
Property, plant and equipment, net | 11,727 | 11,921 | ||||||||
Intangible assets, net | 2,685 | 3,112 | ||||||||
Other long-term assets | 945 | 1,459 | ||||||||
Total assets | $ | 98,667 | $ | 97,681 | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||
Current liabilities | ||||||||||
Accounts payable | $ | 4,040 | $ | 5,950 | ||||||
Accrued payroll and related liabilities | 4,321 | 4,066 | ||||||||
Other accrued liabilities | 3,617 | 5,632 | ||||||||
Customer advances | 14,979 | 3,625 | ||||||||
Total current liabilities | 26,957 | 19,273 | ||||||||
Other long-term liabilities | 2,883 | 2,411 | ||||||||
Stockholders’ equity | ||||||||||
Common stock ( |
21 | 20 | ||||||||
Additional paid in capital | 169,059 | 166,514 | ||||||||
|
(28,489 | ) | (28,489 | ) | ||||||
Accumulated other comprehensive income | 491 | 412 | ||||||||
Accumulated deficit | (72,255 | ) | (62,460 | ) | ||||||
Total stockholders’ equity | 68,827 | 75,997 | ||||||||
Total liabilities and stockholders’ equity | $ | 98,667 | $ | 97,681 | ||||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (Unaudited, in thousands, except per share amounts) |
||||||||||||||||
Three months ended | Six months ended | |||||||||||||||
July 2,
2016 |
July 4,
2015 |
July 2,
2016 |
July 4,
2015 |
|||||||||||||
Non-GAAP Income (Loss) from Operations | ||||||||||||||||
Reported operating income (loss) (GAAP basis) | $ | (3,807 | ) | $ | 283 | $ | (10,124 | ) | $ | (2,657 | ) | |||||
Restructuring charges1 | — | — | — | 148 | ||||||||||||
Change in fair value of contingent consideration obligations2 | (158 | ) | (174 | ) | (142 | ) | (200 | ) | ||||||||
Non-GAAP Operating Income (Loss) | $ | (3,965 | ) | $ | 109 | $ | (10,266 | ) | $ | (2,709 | ) | |||||
Non-GAAP Net Loss | ||||||||||||||||
Reported net income (loss) (GAAP basis) | $ | (3,490 | ) | $ | 12 | $ | (9,795 | ) | $ | (2,881 | ) | |||||
Restructuring charges1 | — | — | — | 148 | ||||||||||||
Change in fair value of contingent consideration obligations2 | (158 | ) | (174 | ) | (142 | ) | (200 | ) | ||||||||
Non-GAAP Net Loss | $ | (3,648 | ) | $ | (162 | ) | $ | (9,937 | ) | $ | (2,933 | ) | ||||
Non-GAAP Loss Per Diluted Share | ||||||||||||||||
Reported net income (loss) per diluted share (GAAP basis) | $ | (0.17 | ) | $ | 0.00 | $ | (0.48 | ) | $ | (0.13 | ) | |||||
Restructuring charges1 | — | — | — | $ | 0.01 | |||||||||||
Change in fair value of contingent consideration obligations2 | $ | (0.01 | ) | $ | (0.01 | ) | $ | (0.01 | ) | $ | (0.01 | ) | ||||
Non-GAAP Loss Per Diluted Share | $ | (0.18 | ) | $ | (0.01 | ) | $ | (0.48 | ) | $ | (0.13 | ) | ||||
Weighted average number of diluted shares | 20,691 | 22,912 | 20,621 | 22,929 |
1Results for all periods presented include severance and other employee-related costs related to various restructuring programs.
2Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160801005457/en/
Chief Financial Officer
or
Investor Relations
Source: